Top Tweets for #VERSATILE002

almost 4 years ago

#PDSBiotech Independent Data Monitoring Committee Recommends #VERSATILE002 Trial Continuation without Modifications $PDSB https://t.co/KNKdxLRy0R

1stOncology @1stOncology

about 4 years ago

#PDSBiotech Announces Presentation of Efficacy and Safety Data from #VERSATILE002 Phase 2 Clinical Trial in #Recurrent or #Metastatic #Head and #Neck #Cancer at #ASCO22 $PDSB https://t.co/EMGxfslWVQ

Faraz @farazsid47

over 4 years ago

“We continue to be encouraged by the data and look forward to the presentation of safety data from this study,” said Dr. Lauren V. Wood, Chief Medical Officer of PDS Biotech. Feb 24-26 it is $PDSB #Versatile002 @Pharmdca @Benchpressers @BiotechBiggums

Bio Stocks™

@BioStocks

over 4 years ago

$PDSB Announces Presentation of PDS0101 Data at the 2022 Multidisciplinary Head and Neck Cancers Symposium. $MRK https://t.co/NF9wbbtYSH

Top Tweets for #VERSATILE002

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users